文献速递生殖医学

正常排卵患者冻融胚胎移植中不同子宫内膜准备方案的妊娠结局比较

Comparison of different endometrial preparation protocols on frozen embryo transfer pregnancy outcome in patients with normal ovulation.
PubMed 文献 · Reprod Biomed Online · 2022-07-04

本研究纳入2849例正常排卵行冻融胚胎移植的患者,分为激素替代周期组(n=2115)、来曲唑周期组(n=532)和自然周期组(n=202),采用逆概率治疗加权减少选择偏倚。来曲唑组活产率高于激素替代周期组(OR 1.18,95%CI 1.06至1.33)和自然周期组(OR 1.24,95%CI 1.11至1.41),校正混杂因素后活产率仍持续较高。

要点

  • 来曲唑组活产率高于激素替代周期组(OR 1.18,95%CI 1.06至1.33)和自然周期组(OR 1.24,95%CI 1.11至1.41)。
  • 来曲唑组生化妊娠率、临床妊娠率、持续妊娠率和足月分娩率均较高。
  • 校正混杂因素后,来曲唑组活产率仍持续高于激素替代周期组和自然周期组。

核心结论

  • 对于月经周期正常的不孕女性行冻融胚胎移植,来曲唑轻度刺激周期较激素替代周期和自然周期具有相对较大优势,活产率更高,提示来曲唑给药可改善该人群的妊娠结局。

研究设计与样本

  • 研究纳入2849例患者,分为激素替代周期组(n=2115)、来曲唑周期组(n=532)和自然周期组(n=202),采用逆概率治疗加权按基线协变量均衡各组,主要妊娠结局为活产率。

主要发现

  • 粗分析中,来曲唑组活产率高于激素替代周期组(OR 1.18,95%CI 1.06至1.33)和自然周期组(OR 1.24,95%CI 1.11至1.41)。
  • 校正混杂因素后,来曲唑组活产率仍持续高于激素替代周期组和自然周期组。
  • 来曲唑组生化妊娠率、临床妊娠率、持续妊娠率和足月分娩率均高于激素替代周期组和自然周期组。

临床怎么用

  • 原文结论提示,对月经周期正常的不孕女性行冻融胚胎移植时,来曲唑轻度刺激周期可改善妊娠结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What is the effect of letrozole use in patients undergoing frozen embryo transfer (FET) with normal ovulation? Although the number of FETs is increasing, an optimal protocol for FET (particularly vitrified-warmed embryo transfer) is yet to be determined. The aim of this study was to evaluate letrozole use on patients with normal menstrual cycles compared with hormone replacement therapy (HRT) cycles and natural cycles. DESIGN: The study involved 2849 patients. Patients were divided into three groups: HRT cycle (n = 2115), letrozole cycle (n = 532) and natural cycle (n = 202). Inverse probability of treatment weighting aimed to equate each group according to measured baseline covariates to achieve a comparison with reduced selection bias and live birth rate as main pregnancy outcome was analysed. RESULTS: In the crude analysis, the letrozole group had a higher live birth rate compared with the HRT cycle (OR 1.18, 95% CI 1.06 to 1.33) and natural cycle (OR 1.24, 95% CI 1.11 to 1.41); after adjusting for confounding factors, live birth rate was consistently higher in the letrozole group. Moreover, the biochemical pregnancy, clinical pregnancy, ongoing pregnancy and full-term delivery rates were higher in the letrozole group. CONCLUSION: For infertile women with normal menstrual cycle undergoing FET, mildly stimulated cycles with letrozole present a relatively large advantage compared with HRT cycle and natural cycle, with higher live birth pregnancy, indicating that letrozole administration could improve pregnancy outcomes in this population.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Lou L, Xu Y, Lv M, et al. Comparison of different endometrial preparation protocols on frozen embryo transfer pregnancy outcome in patients with normal ovulation. Reprod Biomed Online. 2022. PMID: 36085270. doi:10.1016/j.rbmo.2022.06.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。